The role of IL-12 on day 2 was confirmed through its direct nasal application, and nasal administration of IL-12 reduced the virus yield in the bronchoalveolar fluids from influenza-infected mice (Hama, et al., 2009; Kurokawa, et al., 2002; Tsurita, et al., 2001) .